You are here: Industry Insights > R&D

News List

GlaxoSmithKline sharpens ax for 650 job cuts—450 in sales—to channel money toward new launches, R&D fiercepharma
September 28, 2018
After a business review unveiled in July—and ahead of new challenges—GlaxoSmithKline is sharpening its jobs ax to cut 650 across its U.S. business. On the block are 450 field sales positions, plus another 100 each at its ...
400 jobs to go as Novo Nordisk overhauls R&D operations pharmafile
September 20, 2018
Novo Nordisk has revealed its intention to restructure its research & development operations “to accelerate the expansion and...
SDA to Speed Up the New Drug R&D: Clinical Trials Can be Conducted within 60 Days without being Negated or Questioned Yuntian
August 07, 2018
The State Drug Administration of China (SDA) has recently released the Announcement on Adjusting the Review and Approval
Sanofi invests €66m in Chinese R&D hub pharmafile
July 06, 2018
French multinational Sanofi is investing €66 million in a tech-focused operation in China in an effort to increase efficiency and speed up the analysis of clinical trials
Boehringer Ingelheim Bolsters Biologics R&D contractpharma
July 03, 2018
Boehringer Ingelheim has unveiled plans to invest €230 million into a new Biologicals Development Center (BDC) at the company's research and development site in Biberach, Germany during the foundation stone laying for the new center.
Boehringer to invest €230m in biologics R&D pharmaceutical-technology
June 28, 2018
Boehringer Ingelheim has revealed plans to invest €230m into a new Biologicals Development Center (BDC) set to be constructed at its Research and Development (R&D) site located in Biberach, Germany.
Sanofi, Translate Bio ink mRNA vaccine R&D deal worth up to $805M fiercevaccines
June 26, 2018
Moving to expand its vaccine pipeline after some slip-ups last year, Sanofi is betting on Translate Bio's mRNA platform in up to five undisclosed infectious disease targets.
Where is Pfizer putting its R&D hopes? Vaccines are front and center fiercepharma
May 08, 2018
On Pfizer’s first-quarter earnings call, CEO Ian Read drew up a long list of R&D programs the company’s expecting to drive future growth. But when Bernstein analyst Tim Anderson asked him to narrow it down, Read mentioned vaccines first.
Atara hires ex-Genentech SVP to lead global R&D fiercebiotech
May 08, 2018
Atara Biotherapeutics has named Dietmar Berger, M.D., Ph.D., as its global head of R&D. Berger joins after seven years at Roche’s Genentech, during which time he had a hand in the approval of drugs including PD-L1 checkpoint inhibitor Tecentriq.
India and Japan sign 15 agreements including biotech, R&D, and science biospectrumasia
September 19, 2017
India and Japan sign 15 agreements including biotech, R&D, and science There was an agreement to establish a joint exchange programme to identify and foster talented young scientists from both countries to collaborate in the field of theoretical biology.

Previous page 1 2 3 4 5 6 7 Next page